Robert Graifman
Angel · Florida
Verified active in the last 12 months
Board director at 2 startups that filed Form D raises since late 2024, mostly in Florida.
- Stages
- Pre-seed, Seed
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jun 2026
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Thylacine BiotherapeuticsJan 19, 2023
- SEC Form D: Illuminare BiotechnologiesJun 4, 2026
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.